All proposals of the Board of Directors approvedSeverin Schwan elected as new Chairman of the Board of Directors; all other members of the Board of Directors standing for election were electedThomas Schinecker
Basel, 2 February 2023 Group sales grow by 2%1 at constant exchange rates (CER) and 1% in Swiss francs, despite lower COVID-19-related sales in both divisionsPharmaceuticals Division sales increase
Roche warned of a decline in 2023 earnings, as revenue growth from new drugs, including its haemophilia treatment and multiple sclerosis drug, would not make up for a steep demand drop for COVID-19